ArticleCurrent oncology (Toronto, Ont.)2026

Durable Hematologic Response in Therapy-Related Myelodysplastic Syndrome During Nivolumab Treatment for Metastatic Melanoma: A Case Report.

Fathima Nashfa M Hamza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.